MARATTO

article · PubMed

Attitude and Practices Towards Breast Cancer Among Undergraduate Female Pharmacy Students in Pakistan

Abstract

Background: Lack of knowledge, attitude and perception towards breast cancer still a major public health issue disease in many developed and under-developed countries including Pakistan. In 2024 in Pakistan, one in every 8 females is affected by Breast Cancer. Objective: To determine the awareness, attitude, and practices of Pharmacy (Pharm-D) students towards Breast Cancer (BC) and their correlation with participants' age and level of study. Methodology: online sample size calculator with a 5.0% margin of error and a 95.0% confidence interval was used. The respondents were sampled via convenience sampling. Results: Our sample included 401 participants. The majority gained knowledge about BC from the media (69.8%). About 73.4% of participants did not participate in breast self-examination (BSE), and about 41.3% of them believed they were not at risk. About 92.6% of participants didn't undergo clinical breast examination (CBE). Nearly half of the participants (44.9%) agreed that BC is more common in older women. About four-fifths of the respondents (79.3%) agreed that regular examination can reduce the risk of BC. Conclusion: The practice of BSE by the Pharm.D students is lagging. There were notable gaps in CBE by pharmacy students due to the belief that breast cancer predominantly affects older women. Therefore, it is important to make future pharmacists aware of practicing BSE and CBE regularly.

Research topics

  • Global Cancer Incidence and Screening
  • Medication Adherence and Compliance
  • Cancer Risks and Factors

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.15167/2421-4248/jpmh2025.66.3.3608

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.